Disc Medicine Inc.

NASDAQ: IRON · Real-Time Price · USD
59.92
-0.80 (-1.32%)
At close: Aug 15, 2025, 3:45 PM

Disc Medicine Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 20K 9K 11K 110K 26K 25K 25K 75K 109K 300K n/a n/a n/a 46K 58K 62K 65K
Gross Profit
n/a -20K -9K -11K -110K -26K -25K -25K -75K -109K -300K n/a n/a n/a -46K -58K -62K -65K
Operating Income
-61.41M -39.95M -34.55M -32.86M -30.85M -31.46M -29.71M -18.96M -17.33M -25.13M -21.33M -3.74M -7.23M -15.18M -17.74M -18.45M -16.32M -16.49M
Interest Income
7.06M 6.88M 5.84M 6.36M 4.57M 4.52M 4.68M 4.84M 2.91M 2.37M 52K 499K 149K 9K 4K 5K 5K 1K
Pretax Income
-55.2M -33.97M -29.28M -26.48M -26.29M -26.94M -23.55M -14.1M -15.92M -22.76M -21.23M -3.28M -7.09M -15.23M -17.82M -18.55M -16.45M -19.05M
Net Income
-55.25M -34.09M -29.46M -26.6M -26.35M -26.95M -23.58M -14.12M -15.95M -22.78M -20.43M -2.78M -6.9M -15.22M -17.82M -18.55M -16.45M -19.05M
Selling & General & Admin
15.09M 12.18M 9.75M 8.17M 7.37M 7.76M 7.15M 4.54M 5.23M 4.95M 712K 3.3M 4.65M 5.37M 5.11M 5M 5.48M 4.7M
Research & Development
46.32M 27.76M 24.79M 24.68M 23.48M 23.7M 22.57M 14.42M 12.1M 20.18M 20.61M 438K 2.58M 9.8M 12.63M 13.46M 10.84M 11.79M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a -5K n/a n/a 2K 43K 3K n/a -2K -11K n/a
Operating Expenses
61.41M 39.95M 34.54M 32.86M 30.85M 31.46M 29.71M 18.96M 17.33M 25.13M 21.33M 3.74M 7.23M 15.18M 17.74M 18.45M 16.32M 16.49M
Interest Expense
910K 897K 572K n/a n/a n/a n/a n/a n/a n/a n/a 41K 48K 66K 85K 104K 121K 1.85M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
61.41M 39.95M 34.55M 32.86M 30.85M 31.46M 29.71M 18.96M 17.33M 25.13M 21.33M 3.74M 7.23M 15.18M 17.74M 18.45M 16.32M 16.49M
Income Tax Expense
52K 119K 176K 114K 60K 5K 32K 20K 24K 23K -803K -501K -192K -12K 85K 102K 110K n/a
Shares Outstanding (Basic)
35.02M 33.33M 29.93M 29.93M 25.65M 24.81M 24.36M 24.32M 21.48M 18.95M 11.64M 4.33M 4.32M 4.32M 4.32M 4.31M 4.3M 3.2M
Shares Outstanding (Diluted)
35.02M 33.33M 29.94M 29.94M 25.65M 24.81M 24.36M 24.32M 21.48M 18.95M 11.64M 4.33M 4.32M 4.32M 4.32M 4.31M 4.3M 3.2M
EPS (Basic)
-1.58 -1.02 -0.99 -0.89 -1.03 -1.09 -0.97 -0.58 -0.74 -1.2 -1.75 -0.64 -1.6 -3.52 -4.12 -4.3 -3.82 -5.95
EPS (Diluted)
-1.58 -1.02 -0.99 -0.89 -1.03 -1.09 -0.97 -0.58 -0.74 -1.2 -1.75 -0.64 -1.6 -3.52 -4.12 -4.3 -3.82 -5.95
EBITDA
-54.2M -33.05M -13.25M -32.84M -30.74M -31.44M -29.69M -18.93M -17.3M -25.1M -21.27M -10.46M -11.99M -9.94M -17.69M -18.39M -16.26M -17.14M
EBIT
-54.28M -33.07M -13.26M -32.86M -30.85M -31.46M -29.71M -18.96M -17.33M -25.13M -21.57M -10.48M -12.02M -9.96M -17.74M -18.45M -16.33M -17.2M
Depreciation & Amortization
85K 20K 9K 11K 110K 26K 25K 25K 75K 109K 300K 24K 22K 18K 46K 58K 62K 65K